A 58-year-old man with type 2 diabetes mellitus and chronic kidney disease (eGFR 22 mL/min/1.73 m²) presents with palpitations and generalized weakness for 2 days. He has been taking lisinopril 10 mg daily and spironolactone 25 mg daily for hypertension. On examination, heart rate is 52 bpm and regular. ECG shows peaked T waves in precordial leads, prolonged PR interval, and widened QRS complex (120 ms). Serum potassium is 7.8 mEq/L, sodium 138 mEq/L, chloride 104 mEq/L, bicarbonate 22 mEq/L. What is the most appropriate immediate management?

Explanation

## Clinical Presentation & Diagnosis This patient has **severe symptomatic hyperkalemia** (K⁺ = 7.8 mEq/L) with life-threatening **ECG changes** (peaked T waves, prolonged PR interval, widened QRS) indicating imminent risk of ventricular fibrillation and cardiac arrest. **Key Point:** Peaked T waves and QRS widening are ominous signs requiring **immediate cardioprotection and rapid potassium shift**, not gradual elimination. ## Immediate Management Algorithm ```mermaid flowchart TD A[Severe hyperkalemia + ECG changes]:::urgent --> B[Cardiac membrane stabilization]:::action B --> C[IV Calcium gluconate 10%]:::action C --> D{K+ shift needed?}:::decision D -->|Yes| E[Insulin + dextrose IV]:::action D -->|Yes| F[Sodium bicarbonate IV]:::action E --> G[Monitor K+ q2-4h]:::outcome F --> G A --> H[Remove K+ source]:::action H --> I[Stop ACE-I/ARB/K-sparing diuretics]:::action I --> J[Consider dialysis if refractory]:::action ``` ## Why This Approach ### Calcium Gluconate (First-Line) - **Mechanism:** Stabilizes cardiac myocyte membrane potential; does NOT lower K⁺ but prevents arrhythmias. - **Dose:** 10% solution, 10–20 mL IV over 2–5 minutes (can repeat in 5 min if ECG changes persist). - **Onset:** 1–3 minutes. - **Contraindication:** Digitalis toxicity (risk of arrhythmia) — not present here. **High-Yield:** Calcium is the **only agent that works on the heart directly**; it buys time for K⁺-lowering therapies. ### Insulin + Dextrose (Second-Line) - **Mechanism:** Insulin drives K⁺ intracellularly via Na⁺-K⁺-ATPase activation. - **Dose:** Regular insulin 10 units IV + dextrose 25 g (50 mL of 50% dextrose) to prevent hypoglycemia. - **Onset:** 10–20 minutes. - **Effect:** Lowers K⁺ by 0.5–1.2 mEq/L over 4–6 hours. ### Sodium Bicarbonate (Adjunctive) - **Mechanism:** Alkalinization shifts K⁺ intracellularly; also buffers acidosis (which worsens hyperkalemia). - **Dose:** 50–100 mEq IV over 5–10 minutes (especially effective if metabolic acidosis present). - **Onset:** 30–60 minutes. ### Remove Potassium Source - **Discontinue:** Lisinopril (ACE inhibitor) and spironolactone (K⁺-sparing diuretic) — both reduce renal K⁺ excretion. - **Diuretics:** Furosemide alone is insufficient in severe hyperkalemia with CKD; patient's GFR is too low for adequate natriuresis. ### Dialysis Consideration - Reserved for **refractory cases** (K⁺ >7 mEq/L unresponsive to medical therapy, or severe CKD with oliguria). - Not first-line here, but may be needed if medical therapy fails. **Clinical Pearl:** In CKD with hyperkalemia, the **combination of calcium + insulin/dextrose + bicarbonate** addresses both cardiac safety and K⁺ redistribution; dialysis is the definitive K⁺ removal method if these fail. ## Why Spironolactone Discontinuation Alone Is Insufficient **Warning:** Stopping spironolactone alone takes days to weeks to lower K⁺ significantly. With ECG changes present, the patient needs **immediate cardioprotection and rapid K⁺ shift within minutes to hours**. ## Sodium Polystyrene Sulfonate (Kayexalate) **High-Yield:** Cation exchange resin that binds K⁺ in the colon; **onset 4–24 hours**. Useful for **chronic/mild hyperkalemia** but **contraindicated in acute symptomatic hyperkalemia** because it is too slow and carries risk of colonic necrosis (especially in CKD). [cite:Harrison 21e Ch 280]